Different patterns of stromal and cancer cell thymidine phosphorylase reactivity in non-small-cell lung cancer: impact on tumour neoangiogenesis and survival

被引:106
|
作者
Koukourakis, MI [1 ]
Giatromanolaki, A
Kakolyris, S
O'Byrne, KJ
Apostolikas, N
Skarlatos, J
Gatter, KC
Harris, AL
机构
[1] Univ Hosp Irakl, Dept Radiotherapy Oncol, Iraklion 71110, Greece
[2] Univ Hosp Irakl, St Nikolas Histopathol Unit, Iraklion 71110, Greece
[3] Oxford Radcliffe Hosp, Dept Cellular Sci, Oxford OX3 7LJ, England
[4] Oxford Radcliffe Hosp, Dept ICRF, Med Oncol Unit, Oxford OX3 7LJ, England
[5] Hellen Canc Inst, Dept Radiat Oncol, Athens, Greece
[6] Hellen Canc Inst, Dept Histopathol, Athens, Greece
关键词
PD-ECGF; thymidine phosphorylase fibroblast; macrophage; lung cancer;
D O I
10.1038/bjc.1998.280
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Angiogenesis is recognized as an important step in tumour pathogenesis that is related to invasion and metastatic spread and which consequently results in poor clinical outcome. In this study, we have examined the role of tumour stroma-activated fibroblasts and macrophage infiltration in the development of the angiogenic and metastatic phenotype in non-small-cell lung cancer (NSCLC). A total of 141 cases of early stage I-Il NSCLC treated with surgery alone were analysed. The JC-70 (anti-CD31) MAb was used for the assessment of vascular grade. The P-GF.44C MAb was used to assess thymidine phosphorylase (TP) reactivity in cancer cells, stromal fibroblasts and macrophages, Cancer cell TP overexpression related to high vascular grade and to advanced T stage (P = 0.0004 and P = 0.02). Expression of TP in stromal fibroblasts also correlated with high angiogenesis (P = 0.01), but was independent of cancer cell expression. Fibroblast TP overexpression was related to abundant stroma (P=0.003), suggesting that TP may be a marker of active stroma, Moreover, intense macrophage infiltration was associated with fibroblast TP reactivity, regardless of the amount of stroma, suggesting that macrophages may be a major contributor to TP expression in stroma. Survival analysis showed that cancer cell TP overexpression was related to poor prognosis (P = 0.005). Although stroma TP is related to angiogenesis, in the low vascular grade group it defined a group of patients with better prognosis (P = 0.02). It may be that fibroblast TP reactivity is an indirect marker of tumour infiltration by functional macrophages, which have an anti-tumour effect, We conclude that stromal macrophage and fibroblast TP reactivity may have an important role in non-small-cell lung cancer behaviour. Understanding the role of stromal fibroblasts and inflammatory cells and their interaction with oncoprotein expression is essential for the elucidation of lung cancer pathogenesis.
引用
收藏
页码:1696 / 1703
页数:8
相关论文
共 50 条
  • [21] Acute vascular response to cediranib treatment in human non-small-cell lung cancer xenografts with different tumour stromal architecture
    Jiang, Yanyan
    Allen, Danny
    Kersemans, Veerle
    Devery, Aoife M.
    Bokobza, Sivan M.
    Smart, Sean
    Ryan, Anderson J.
    LUNG CANCER, 2015, 90 (02) : 191 - 198
  • [22] Different glomerulopathies accompanying non-small-cell lung cancer
    Paydas, S
    Soydas, B
    Paydas, S
    Balal, M
    Erdogan, S
    Tuncer, I
    MOUNT SINAI JOURNAL OF MEDICINE, 2005, 72 (04): : 279 - 281
  • [23] Impact of intrapulmonary tumour location of non-small-cell lung cancer on surgical outcomes for segmentectomy
    Matsui, Takuya
    Takahashi, Yusuke
    Nakada, Takeo
    Sugita, Yusuke
    Seto, Katsutoshi
    Sakakura, Noriaki
    Mizuno, Kotaro
    Haneda, Hiroshi
    Okuda, Katsuhiro
    Kuroda, Hiroaki
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2024, 65 (03)
  • [24] Macrophage and mast cell invasion of tumour cell islets confers a marked survival benefit in non-small-cell lung cancer
    O'Byrne, K
    Welsh, T
    Green, R
    Richardson, D
    Waller, D
    Bradding, R
    LUNG CANCER, 2005, 49 : S95 - S96
  • [25] Cancer vaccines for non-small-cell lung cancer
    Palma, M.
    Choudhury, A.
    Mellstedt, H.
    MINERVA CHIRURGICA, 2009, 64 (06) : 643 - 653
  • [26] Survival and treatment patterns in elderly patients with advanced non-small-cell lung cancer in Manitoba
    Ott, C. L. Baunemann
    Ratna, N.
    Prayag, R.
    Nugent, Z.
    Badiani, K.
    Navaratnam, S.
    CURRENT ONCOLOGY, 2011, 18 (05) : E238 - E242
  • [27] Leveraging Treatment Patterns to Predict Survival of Patients with Advanced Non-Small-Cell Lung Cancer
    Haas, Kyle
    Mahoui, Malika
    Gupta, Simone
    Morton, Stuart
    ACM-BCB'18: PROCEEDINGS OF THE 2018 ACM INTERNATIONAL CONFERENCE ON BIOINFORMATICS, COMPUTATIONAL BIOLOGY, AND HEALTH INFORMATICS, 2018, : 283 - 290
  • [28] Overall survival benefit in advanced non-small-cell lung cancer
    Owen, Olwen Glynn
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2008, 69 (07) : 379 - 379
  • [29] NON-SMALL-CELL LUNG CANCER SURVIVAL ACCORDING TO HOSPITAL TYPE
    Morgensztern, Daniel
    Waqar, Saiama N.
    Subramanian, Janakiraman
    Detterbeck, Frank C.
    Govindan, Ramaswamy
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1429 - S1429
  • [30] Non-small-cell lung cancer: Practice patterns of extrathoracic imaging
    Wong, J
    Haramati, LB
    Rozenshtein, A
    Yanez, M
    Austin, JHM
    ACADEMIC RADIOLOGY, 1999, 6 (04) : 211 - 215